Clinical Trial

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.

Study acronym: TADs
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trials is to compare two diameters, 1.6 and 2 mm, of mini implants both are 12 mm length placed in the infrazygomatic crest region. The main questions it aims to answer are: which diameter is more suitable for IZC region 1.6 or 2mm in terms of primary stability, secondary stability, pain perception and failure rate. 20 participant will receive 40 mini implant bilaterally (20 in one side of 1.6mm, the other side 20 of 2mm). participants will be asked to record visual analog scale (VAS) for 3 nights monitored monthly by the investigator.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-01.
Status change: Not Yet Recruiting → Recruiting 2026-01-15
Trial Details
NCT Number NCT07337538
Lead Sponsor University of Baghdad
Conditions Implant Stability
Enrollment 20 participants
Start Date 2026-01-14
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-20